Your browser doesn't support javascript.
loading
Riok3 inhibits the antiviral immune response by facilitating TRIM40-mediated RIG-I and MDA5 degradation.
Shen, Yong; Tang, Kejun; Chen, Dongdong; Hong, Mengying; Sun, Fangfang; Wang, SaiSai; Ke, Yuehai; Wu, Tingting; Sun, Ren; Qian, Jing; Du, Yushen.
Afiliação
  • Shen Y; Cancer Institute, ZJU-UCLA Joint Center for Medical Education and Research, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, P.R. China; Department of Breast Surgery, The First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, P.R. China.
  • Tang K; Cancer Institute, ZJU-UCLA Joint Center for Medical Education and Research, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, P.R. China; Department of Surgery, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, P.R. China.
  • Chen D; Cancer Institute, ZJU-UCLA Joint Center for Medical Education and Research, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, P.R. China.
  • Hong M; Cancer Institute, ZJU-UCLA Joint Center for Medical Education and Research, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, P.R. China.
  • Sun F; Cancer Institute, ZJU-UCLA Joint Center for Medical Education and Research, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, P.R. China.
  • Wang S; Department of Colorectal Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, P.R. China.
  • Ke Y; Department of Pathology and Pathophysiology, Program in Molecular Cell Biology, Zhejiang University School of Medicine, Hangzhou, China.
  • Wu T; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
  • Sun R; Cancer Institute, ZJU-UCLA Joint Center for Medical Education and Research, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, P.R. China; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Ange
  • Qian J; Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, P.R. China. Electronic address: jingqian@zju.edu.cn.
  • Du Y; Cancer Institute, ZJU-UCLA Joint Center for Medical Education and Research, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, P.R. China; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Ange
Cell Rep ; 35(12): 109272, 2021 06 22.
Article em En | MEDLINE | ID: mdl-34161773
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Proteínas Serina-Treonina Quinases / Ubiquitina-Proteína Ligases / Proteólise / Proteína DEAD-box 58 / Helicase IFIH1 Induzida por Interferon / Imunidade Limite: Animals Idioma: En Revista: Cell Rep Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Proteínas Serina-Treonina Quinases / Ubiquitina-Proteína Ligases / Proteólise / Proteína DEAD-box 58 / Helicase IFIH1 Induzida por Interferon / Imunidade Limite: Animals Idioma: En Revista: Cell Rep Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos